Historical Stock Price
ACAD historical stock prices picture
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on February 21, 2024, ACAD opened at $24.68, traded as high as $25.03 and as low as $24.47, and closed at $24.87. Trading volume was a total of 1.11M shares. On February 22, 2024, ACAD opened at $24.89, traded as high as $25.10 and as low as $24.44, and closed at $24.85. Trading volume was a total of 1.03M shares. On February 23, 2024, ACAD opened at $24.93, traded as high as $25.25 and as low as $24.60, and closed at $24.78. Trading volume was a total of 1.40M shares. On February 26, 2024, ACAD opened at $24.67, traded as high as $25.97 and as low as $24.64, and closed at $25.90. Trading volume was a total of 1.46M shares. On February 27, 2024, ACAD opened at $26.04, traded as high as $26.56 and as low as $25.60, and closed at $26.36. Trading volume was a total of 2.06M shares.

ACAD Historical Stock Prices By Date:

ACAD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/03/2014
End date: 02/27/2024
Start price/share: $28.19
End price/share: $26.36
Dividends collected/share: $0.00
Total return: -6.49%
Average Annual Total Return: -0.67%
Starting investment: $10,000.00
Ending investment: $9,350.19
Years: 9.99
Date Open High Low Close Volume
02/21/2024 $24.68 $25.03 $24.47 $24.87 1.11M
02/22/2024 $24.89 $25.10 $24.44 $24.85 1.03M
02/23/2024 $24.93 $25.25 $24.60 $24.78 1.40M
02/26/2024 $24.67 $25.97 $24.64 $25.90 1.46M
02/27/2024 $26.04 $26.56 $25.60 $26.36 2.06M
Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system disorders. Co. has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. NUPLAZID is a selective serotonin inverse agonist/antagonist, targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors.
Date Close
02/21/2024$24.87
02/22/2024$24.85
02/23/2024$24.78
02/26/2024$25.90
02/27/2024$26.36
ACAD is categorized under the Healthcare sector; below are some other companies in the same sector:

ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices
ACT Historical Stock Prices

Also explore: ACAD shares outstanding history

Email EnvelopeFree ACAD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ACAD Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.